Growth Metrics

Incyte (INCY) Property, Plant & Equipment (Net) (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Incyte 19.28 Bn 15.27 Bn 1.17 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.47%
Dec 31, 2025 -8.48%
Sep 30, 2025 0.01%
Jun 30, 2025 4.34%
Mar 31, 2025 0.26%
Dec 31, 2024 -1.25%
Sep 30, 2024 1.46%
Jun 30, 2024 5.83%
Mar 31, 2024 -4.19%
Dec 31, 2023 2.52%
Sep 30, 2023 -2.18%
Jun 30, 2023 1.03%
Mar 31, 2023 0.32%
Dec 31, 2022 3.29%
Sep 30, 2022 -0.78%
Jun 30, 2022 -1.08%
Mar 31, 2022 0.73%
Dec 31, 2021 5.42%
Sep 30, 2021 3.83%
Jun 30, 2021 11.21%
Mar 31, 2021 6.26%
Dec 31, 2020 12.30%
Sep 30, 2020 9.82%
Jun 30, 2020 10.67%
Mar 31, 2020 8.60%
Jun 30, 2019 0.23%
Mar 31, 2019 5.81%
Dec 31, 2018 6.31%
Sep 30, 2018 12.40%
Jun 30, 2018 1.12%
Mar 31, 2018 1.87%
Dec 31, 2017 5.24%
Sep 30, 2017 12.77%
Jun 30, 2017 13.28%
Mar 31, 2017 15.23%
Dec 31, 2016 10.36%
Sep 30, 2016 9.70%
Jun 30, 2016 49.55%
Mar 31, 2016 7.69%
Dec 31, 2015 3.39%
Sep 30, 2015 1.94%
Jun 30, 2015 1.16%
Mar 31, 2015 -1.37%
Dec 31, 2014 8.68%
Sep 30, 2014 35.34%
Jun 30, 2014 43.86%
Mar 31, 2014 43.97%
Dec 31, 2013 332.96%
Sep 30, 2013 -0.56%
Jun 30, 2013 -3.84%
Mar 31, 2013 2.16%
Dec 31, 2012 2.90%
Sep 30, 2012 -5.31%
Jun 30, 2012 4.54%
Mar 31, 2012 -3.09%
Dec 31, 2011 5.83%
Sep 30, 2011 10.49%
Jun 30, 2011 11.47%
Mar 31, 2011 2.71%